B takeover of Insmed and its blockbuster lung drug Brinsupri as the French pharma giant braces for Dupixent’s looming patent ...
Four principles for getting AI agents past the pilot phase in regulated pharma manufacturing. AI agents are the latest ...
With rising healthcare costs, practices are embracing flexible payment models and upfront pricing transparency to keep care accessible.
J&J’s separations of Kenvue and DePuy Synthes test whether Innovative Medicine and MedTech create more value together than ...
Regeneron's Livsayis (cemdisiran) gains FDA approval for adults with antibody-positive generalized myasthenia gravis, dosed ...
DISCO Pharmaceuticals gets $40M upfront from AbbVie and could earn up to $2.5B in milestones to develop AND-gated bispecifics ...
As specialty drug complexity grows, agentic technology puts the right access, adherence, and affordability resources at the ...
Dr. Joe Geraci of NetraMark explains how AI analysis of clinical trial data can uncover hidden responder subgroups, separate ...
The White House has withdrawn Dr. Heidi Overton’s nomination for FDA commissioner just a day before a Senate committee vote.
Parexel’s Stacy Hurt explains why AI can speed up clinical research but can’t replace the lived experience of patients.
White House withdraws Dr. Heidi Overton’s FDA commissioner nomination amid Senate GOP pushback, Pfizer and Verismo advance in vivo CAR-T manufacturing through new licensing deals, and Infinitus’s ...
Pharmaceutical Executive spoke with Ankit Jain, CEO and founder of Infinitus, about how agentic AI models are being deployed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results